Login

Company Executives

Management Team

From Forms 3, 4 and 5 filed in the last 18 months
Officer Source
Richard J Daly
President and CEO
Title from the Form 4 dated Jul 15, 2026
Michael Wayne Kalb
Chief Financial Officer
Title from the Form 4 dated Jul 15, 2026
William T. Andrews
Chief Medical Officer
Title from the Form 4 dated Jul 15, 2026
Carmen Jeffrey Del
Chief Commercial Officer
Title from the Form 4 dated Jul 15, 2026
Brian Elsbernd
Chief Legal Officer
Title from the Form 4 dated Jul 15, 2026
Gregg Russo
Chief HR Officer
Title from the Form 4 dated Jul 15, 2026
Preethi Sundaram
Chief Strategy Officer
Title from the Form 4 dated Jul 15, 2026
Steve Miller
Chief Op. & Scientific Officer
Title from the Form 4 dated Jul 15, 2026
Gary Ingenito
Chief Med. & Reg. Officer
Title from the Form 4 dated May 13, 2025

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
3
serving now
Director Source
Sergio Marullo di Condojanni Joined Jul 16, 2026
Massimo Marin Joined Jul 16, 2026
Enrica Dogali Joined Jul 16, 2026
  • An 8-K filed May 23, 2025 says Charles B. O’Keeffe left the board; they could not be matched to a director above.
  • An 8-K filed Jul 16, 2026 says Patrick J. McEnany left the board; they could not be matched to a director above.
  • An 8-K filed Jul 16, 2026 says Richard J. Daly left the board; they could not be matched to a director above.
  • An 8-K filed Jul 16, 2026 says Daniel J. Curran, M.D. left the board; they could not be matched to a director above.
  • An 8-K filed Jul 16, 2026 says Donald A. Denkhaus left the board; they could not be matched to a director above.
  • An 8-K filed Jul 16, 2026 says Molly Harper left the board; they could not be matched to a director above.
  • An 8-K filed Jul 16, 2026 says Tamar Thompson left the board; they could not be matched to a director above.
  • An 8-K filed Jul 16, 2026 says David S. Tierney, M.D. left the board; they could not be matched to a director above.

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 11, 2025 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support